eIF3ε, a subunit of the eukaryotic initiation factor 3 (eIF3) complex, plays a crucial role in the initiation phase of protein synthesis. As a part of this multiprotein complex, eIF3ε contributes to the binding of the 40S ribosomal subunit to mRNA, thereby facilitating the assembly of the active 80S ribosome that is essential for the translation process. The regulation of eIF3ε is integral to the control of protein synthesis, which is a fundamental cellular process affecting growth, proliferation, and the maintenance of cellular functions. Understanding the expression patterns of eIF3ε and identifying compounds that can increase its expression is of significant interest in the context of cellular biology and gene expression regulation.
Several chemical compounds have been identified to potentially induce the expression of eIF3ε. These activators could operate through diverse mechanisms, each intersecting with intricate cellular pathways. Compounds like Epigallocatechin gallate (EGCG) and Resveratrol, for example, are known for their antioxidant properties and could upregulate eIF3ε by engaging cellular defense mechanisms against oxidative stress. This upregulation forms part of a broader cellular strategy to maintain protein homeostasis under adverse conditions. Similarly, Metformin, commonly recognized for its role in metabolic processes, might prompt the expression of eIF3ε by activating AMP-activated protein kinase (AMPK), an enzyme that plays a key role in cellular energy homeostasis. On another front, chemicals like lithium, which is known to alter intracellular signaling, could lead to the enhancement of eIF3ε expression by modulating gene expression profiles that are associated with cellular resilience and neuroprotection. These activators, while diverse in their primary functions, share the common potential to upregulate eIF3ε, highlighting the multifaceted nature of cellular regulation and the broad scope of interactions that can influence protein synthesis at the translational initiation level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate could enhance eIF3ε expression by triggering antioxidant defense mechanisms, leading to the activation of cellular pathways that upregulate stress-responsive genes. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has the potential to elevate eIF3ε expression through sirtuin-mediated pathways, which could recalibrate the cellular stress response and longevity-related processes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium may upregulate eIF3ε expression by altering intracellular signaling cascades, leading to changes in gene transcription profiles associated with neuroprotection and cellular resilience. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin could induce eIF3ε expression as a consequence of its role in enhancing cellular metabolic efficiency, possibly through pathways linked to energy sensing and calorie restriction mimetics. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone may stimulate an increase in eIF3ε expression by engaging transcription factors that govern glucose metabolism and adipogenesis, potentially extending to broader gene expression alterations. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
This hormone could promote eIF3ε expression by binding to estrogen receptors that interact with DNA on estrogen-responsive promoter regions, potentially stimulating gene transcription. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone could elevate eIF3ε expression by enhancing transcriptional activity linked to insulin sensitization and fatty acid storage, possibly extending the effects to various metabolic genes. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram may upregulate eIF3ε by prompting a cellular protective response to toxic metabolites, leading to an increase in expression of genes that facilitate detoxification and stress resistance. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $108.00 $780.00 | 3 | |
Sodium (meta)arsenite might induce eIF3ε expression by eliciting a strong cellular stress response, potentially leading to an upregulation of genes associated with protein folding and stress adaptation. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin could trigger an upsurge in eIF3ε expression by initiating the unfolded protein response, a cellular reaction to misfolded proteins that necessitates increased protein synthesis control. | ||||||